Evidence map›Paper›PMID 40584905›Full record

ArticleBioImpacts : BI2025

Biosynthesis of sulfur quantum dots and cerium oxide nanoparticles for bioimaging and reactive oxygen species modulation in Y79 retinoblastoma cancer cells.

Zahra Foroutan, Sadaf Afshari, Sajjad Njafi, Amir R Afshari, Seyed Sajad Ahmadi, Seyedsina Nemati, Seyedeh Mozhdeh Mirzaei, Afsane Bahrami

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in BioImpacts : BI, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Zahra ForoutanDepartment of Medical Biotechnology & Nanotechnology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.ORCID https://orcid.org/0009-0004-0168-2151
Sadaf AfshariStudent Research Committee, Faculty of Dentistry, Mashhad University of Medical Sciences, Mashhad, Iran.
Sajjad NjafiNeurosurgery Department, Neurovascular Section, Ghaem Hospital, Mashhad University of Medical Sciences, Mashhad, Iran.
Amir R AfshariDepartment of Basic Sciences, Faculty of Medicine, Mashhad Medical Sciences, Islamic Azad University, Mashhad, Iran.
Seyed Sajad AhmadiDepartment of Ophthalmology, Khatam-Ol-Anbia Hospital, Mashhad University of Medical Sciences, Mashhad, Iran.
Seyedsina NematiStudent Research Committee, Faculty of Dentistry, Mashhad University of Medical Sciences, Mashhad, Iran.
Seyedeh Mozhdeh MirzaeiDepartment of Medical Biotechnology & Nanotechnology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
Afsane BahramiClinical Research Development Unit of Akbar Hospital, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.ORCID https://orcid.org/0000-0002-4563-6112

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Retinoblastoma is considered a common cancer in early childhood with a poor prognosis, and innovative strategies for early diagnosis and treatment are essential. The use of nanoparticles is one of the most efficient approaches among these strategies. Methods: Sulfur quantum dots (SQDs) and cerium oxide nanoparticles (CeO Results: The results of characterization confirmed the successful synthesis of SQDs and CeO Conclusion: As the SQDs exhibited green light color and CeO

Indexed as

Cerium oxide nanoparticlesGreen synthesisRetinoblastoma (Y79)Sulfur quantum dots

Identifiers

PMID40584905
PMCPMC12204812

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.